AZA-HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING CANCER
申请人:Les Laboratoires Servier SAS
公开号:EP3902803A1
公开(公告)日:2021-11-03
[EN] AZA-HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING CANCER<br/>[FR] INHIBITEURS AZA-HÉTÉROBICYCLIQUES DE MAT2A ET PROCÉDÉS D'UTILISATION POUR LE TRAITEMENT DU CANCER
申请人:AGIOS PHARMACEUTICALS INC
公开号:WO2020139991A1
公开(公告)日:2020-07-02
The present disclosure provides for compounds according to Formula I and their pharmaceutically acceptable salts, tautomers, and/or isotopologues as described in the disclosure. The compounds are inhibitors of methionine adenosyltransferase isoform 2A (MAT2A). Also provided are pharmaceutical compositions and methods of using the compounds for treating cancers, including some cancers in which the gene encoding methylthioadenosine phosphorylase (MTAP) is deleted.